Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist
Crossref DOI link: https://doi.org/10.1007/s40119-022-00269-3
Published Online: 2022-06-23
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Palanisamy, Srikanth
Funes Hernandez, Mario
Chang, Tara I.
Mahaffey, Kenneth W.
Text and Data Mining valid from 2022-06-23
Version of Record valid from 2022-06-23
Article History
Received: 29 April 2022
Accepted: 7 June 2022
First Online: 23 June 2022